7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
CAS: 2886-65-9
Ref. 3D-FC26451
1g | 177,00 € | ||
2g | 263,00 € | ||
5g | 489,00 € | ||
10g | 694,00 € | ||
500mg | 141,00 € |
Información del producto
- 5-(2-Fluorophenyl)-1,3-dihydro-7-chloro-2H-1,4-benzodiazepin-2-oneNorfludiazepamDesalkylflurazepam
- 2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-
- 2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(o-fluorophenyl)-1,3-dihydro-
- 5-(2-Fluorophenyl)-7-Chloro-1,4-Benzodiazepin-2-One
- 7-Chloro-1,3-dihydro-5-(2′-fluorophenyl)-2H-1,4-benzodiazapin-2-one
- 7-Chloro-5-(2-Fluoro-Phenyl)-1,3-Dihydro-2H-1,4-Benzodiazepin-2-One
- 7-Chloro-5-(o-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
- 7-Chloro-5-(o-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one
- 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
- Cm 7116
- Ver más sinónimos
- Dealkylflurazepam
- Desalkylflurazepam
- Descarbethoxyloflazepate
- N-1-Desalkylflurazepam
- N-Desalkyl-2-oxoquazepam
- N-Desalkylflutoprazepam
- Norflurazepam
- Norflutoprazepam
- Ro 5-3367
- Sch 17514
7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one is a GABA receptor antagonist that is used in the treatment of anxiety. It is an analogue of cinolazepam, which has been shown to inhibit the binding of gamma aminobutyric acid (GABA) to its receptors in human serum and urine samples. Cinolazepam was found to be more potent than 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4 benzodiazepin 2 one in blocking the binding of GABA to its receptor. This drug has also been tested on geriatric patients with high levels of anxiety and found to be well tolerated.
Propiedades químicas
Consulta técnica sobre: 3D-FC26451 7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.